Total Revenue of $64.5 million
Core Revenue grows 1% year-over-year to $63.2 million
Reiterates Full Year 2024 Core Revenue Guidance of $280 million
...
Full Year 2023 Total Revenue of $289.2 million; Q4 2023 Total Revenue of $70.5 million
Full Year 2023 Core Revenue grows 44% year-over-year to $262.1 million; Q4 2023 Core Revenue grows 21%...
/PRNewswire/ -- The "Technology Advancements in Precision Diagnostics and Testing" report has been added to ResearchAndMarkets.com's offering. Precision...
Early access of novel technology that enables preparation of thousands of samples at low cost through self-normalization, enhanced multiplexing, and streamlined workflow
Innovative solution...
/PRNewswire/ -- The "Global Precision Oncology Market Trends and Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This study...
Following Up On Fulgent Genetics (NASDAQ:FLGT) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Myriad Genetics (MYGN) and QIAGEN (QGEN) partner over diagnostics development for cancer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.